EcoDrugPlus

Membrane Metalloendopeptidase

Ensembl ID : ENSOMYG00000042927
Gene Symbol: MME
1 Cross references
230 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSOMYG00000066305
Gene Symbol: MME
1 Cross references
229 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSOMYG00000016269
Gene Symbol: METAP2
1 Cross references
215 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSOMYG00000005237
Gene Symbol: METAP2
1 Cross references
215 Possible Orthologues:

Microtubule-Associated Protein Tau A

Ensembl ID : ENSOMYG00000035281
Gene Symbol: MAPTA
1 Cross references
206 Possible Orthologues:

Microtubule-Associated Protein Tau B

Ensembl ID : ENSOMYG00000041464
Gene Symbol: MAPTB
1 Cross references
180 Possible Orthologues:

Mineralocorticoid Receptor Form A

Ensembl ID : ENSOMYG00000012882
Gene Symbol: MRA
2 Cross references
203 Possible Orthologues:

Mineralocorticoid Receptor Form B

Ensembl ID : ENSOMYG00000010574
Gene Symbol: MRB
2 Cross references
207 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSOMYG00000015316
Gene Symbol: MAPK10
2 Cross references
81 Possible Orthologues:

Mitogen-Activated Protein Kinase 14a

Ensembl ID : ENSOMYG00000022088
Gene Symbol: MAPK14A
1 Cross references
200 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSOMYG00000017877
Gene Symbol: MAPK3
1 Cross references
192 Possible Orthologues:

Mitogen-Activated Protein Kinase 3

Ensembl ID : ENSOMYG00000045959
Gene Symbol: MAPK3
1 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).